Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1996 Dec;149(6):1847–1850.

Cardiotrophin-1 inhibits tumor necrosis factor production in the heart and serum of lipopolysaccharide-treated mice and in vitro in mouse blood cells.

F Benigni 1, S Sacco 1, D Pennica 1, P Ghezzi 1
PMCID: PMC1865339  PMID: 8952522

Abstract

Cardiotrophin-1 (CT-1) is a member of the gp130 family of cytokines that includes interleukin-6, interleukin-11, ciliary neurotrophic factor, leukemia inhibitory factor, and oncostatin M. As interleukin-6, leukemia inhibitory factor, and ciliary neurotrophic factor were previously reported to inhibit the production of tumor necrosis factor (TNF), we studied the effect of CT-1 on serum and heart TNF levels in mice treated with lipopolysaccharide (100 ng/mouse, iv). Co-treatment with CT-1 (5 micrograms/mouse intravenously) markedly inhibit TNF production both in serum and in the heart. The effect of CT-1 seems to be direct as it also inhibited TNF production when added to whole mouse blood cultured with lipopolysaccharide. Thus, CT-1 might play a protective role in some TNF-mediated diseases.

Full text

PDF
1847

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aderka D., Le J. M., Vilcek J. IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. J Immunol. 1989 Dec 1;143(11):3517–3523. [PubMed] [Google Scholar]
  2. Aggarwal B. B., Kohr W. J., Hass P. E., Moffat B., Spencer S. A., Henzel W. J., Bringman T. S., Nedwin G. E., Goeddel D. V., Harkins R. N. Human tumor necrosis factor. Production, purification, and characterization. J Biol Chem. 1985 Feb 25;260(4):2345–2354. [PubMed] [Google Scholar]
  3. Alexander H. R., Wong G. G., Doherty G. M., Venzon D. J., Fraker D. L., Norton J. A. Differentiation factor/leukemia inhibitory factor protection against lethal endotoxemia in mice: synergistic effect with interleukin 1 and tumor necrosis factor. J Exp Med. 1992 Apr 1;175(4):1139–1142. doi: 10.1084/jem.175.4.1139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Benigni F., Fantuzzi G., Sacco S., Sironi M., Pozzi P., Dinarello C. A., Sipe J. D., Poli V., Cappelletti M., Paonessa G. Six different cytokines that share GP130 as a receptor subunit, induce serum amyloid A and potentiate the induction of interleukin-6 and the activation of the hypothalamus-pituitary-adrenal axis by interleukin-1. Blood. 1996 Mar 1;87(5):1851–1854. [PubMed] [Google Scholar]
  5. Benigni F., Villa P., Demitri M. T., Sacco S., Sipe J. D., Lagunowich L., Panayotatos N., Ghezzi P. Ciliary neurotrophic factor inhibits brain and peripheral tumor necrosis factor production and, when coadministered with its soluble receptor, protects mice from lipopolysaccharide toxicity. Mol Med. 1995 Jul;1(5):568–575. [PMC free article] [PubMed] [Google Scholar]
  6. Fattori E., Cappelletti M., Costa P., Sellitto C., Cantoni L., Carelli M., Faggioni R., Fantuzzi G., Ghezzi P., Poli V. Defective inflammatory response in interleukin 6-deficient mice. J Exp Med. 1994 Oct 1;180(4):1243–1250. doi: 10.1084/jem.180.4.1243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Ishikawa M., Saito Y., Miyamoto Y., Kuwahara K., Ogawa E., Nakagawa O., Harada M., Masuda I., Nakao K. cDNA cloning of rat cardiotrophin-1 (CT-1): augmented expression of CT-1 gene in ventricle of genetically hypertensive rats. Biochem Biophys Res Commun. 1996 Feb 15;219(2):377–381. doi: 10.1006/bbrc.1996.0241. [DOI] [PubMed] [Google Scholar]
  8. Latini R., Bianchi M., Correale E., Dinarello C. A., Fantuzzi G., Fresco C., Maggioni A. P., Mengozzi M., Romano S., Shapiro L. Cytokines in acute myocardial infarction: selective increase in circulating tumor necrosis factor, its soluble receptor, and interleukin-1 receptor antagonist. J Cardiovasc Pharmacol. 1994 Jan;23(1):1–6. [PubMed] [Google Scholar]
  9. Pennica D., King K. L., Shaw K. J., Luis E., Rullamas J., Luoh S. M., Darbonne W. C., Knutzon D. S., Yen R., Chien K. R. Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy. Proc Natl Acad Sci U S A. 1995 Feb 14;92(4):1142–1146. doi: 10.1073/pnas.92.4.1142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Pennica D., Shaw K. J., Swanson T. A., Moore M. W., Shelton D. L., Zioncheck K. A., Rosenthal A., Taga T., Paoni N. F., Wood W. I. Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex. J Biol Chem. 1995 May 5;270(18):10915–10922. doi: 10.1074/jbc.270.18.10915. [DOI] [PubMed] [Google Scholar]
  11. Peters M., Roeb E., Pennica D., Meyer zum Büschenfelde K. H., Rose-John S. A new hepatocyte stimulating factor: cardiotrophin-1 (CT-1). FEBS Lett. 1995 Sep 25;372(2-3):177–180. doi: 10.1016/0014-5793(95)00972-c. [DOI] [PubMed] [Google Scholar]
  12. Richards C. D., Langdon C., Pennica D., Gauldie J. Murine cardiotrophin-1 stimulates the acute-phase response in rat hepatocytes and H35 hepatoma cells. J Interferon Cytokine Res. 1996 Jan;16(1):69–75. doi: 10.1089/jir.1996.16.69. [DOI] [PubMed] [Google Scholar]
  13. Sheng Z., Pennica D., Wood W. I., Chien K. R. Cardiotrophin-1 displays early expression in the murine heart tube and promotes cardiac myocyte survival. Development. 1996 Feb;122(2):419–428. doi: 10.1242/dev.122.2.419. [DOI] [PubMed] [Google Scholar]
  14. Sturk A., Hack C. E., Aarden L. A., Brouwer M., Koster R. R., Sanders G. T. Interleukin-6 release and the acute-phase reaction in patients with acute myocardial infarction: a pilot study. J Lab Clin Med. 1992 May;119(5):574–579. [PubMed] [Google Scholar]
  15. Ulich T. R., Fann M. J., Patterson P. H., Williams J. H., Samal B., Del Castillo J., Yin S., Guo K., Remick D. G. Intratracheal injection of LPS and cytokines. V. LPS induces expression of LIF and LIF inhibits acute inflammation. Am J Physiol. 1994 Oct;267(4 Pt 1):L442–L446. doi: 10.1152/ajplung.1994.267.4.L442. [DOI] [PubMed] [Google Scholar]
  16. Waring P. M., Waring L. J., Billington T., Metcalf D. Leukemia inhibitory factor protects against experimental lethal Escherichia coli septic shock in mice. Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1337–1341. doi: 10.1073/pnas.92.5.1337. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES